Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by Mole101on Apr 02, 2021 9:55pm
112 Views
Post# 32933102

RE:Extra Extra! Read All About It! If You Subscribe To BioPub!

RE:Extra Extra! Read All About It! If You Subscribe To BioPub!

You are WRONG again ! Not a Biopub subscriber .. to smart in your mind as always .. the rest is bla bla bla, basher in full mode !


quote=BitHorse]

Laliberte2020, you’re asking a mole 101 who is a biopub subscriber. He/she is simply attempting to do the blocking and tackling. Anyone with an once of sense and pride knows it's a conflict of interest. Regardless of what was discussed the CEO, VP, and Medical Advisor of Algernon showed up on a forum representing the company and gave a small group of investors encouragement moving forward. Meanwhile everyone else is still in  daze. Has anyone else seen or heard from the new VP at Algernon? The BioPub gang already have a nickname for him. It's CB. Their yucking it up at the Pub with the new VP. There's plenty of stuff they talked about that we should know about. Like the idea of Algernon moving it's main office to the USA. That's a big deal if true. It could give someone a different perspective in the USA regarding how they view the company - other than some sleazy little operation in a strip mall setup. Which is the point of their move. They want more eyes on the DMT part of the company. The USA could give them better exposure. There's probably a litany of topics they went over in depth that we will never hear about. If you go back to I believe the last biopub appearance where WE ALL could participate in, the mike was open before the webcast got underway. Dr. KSS told his followers he answered a ton of questions for the company prior to the CEO coming on so it would cut down on the time left for a Q & A. They are having meetings before the meeting. They know what they are doing is wrong and simply believe we are not going to do anything about it. It's not like Dr. KSS doesn't already have prior ethics problems. Now he's cashing in on it on our backs. That's how I see it, along with the CEO's long history of sucking up to Kal Mali. Malhi controls Growmax Capital's millions of institutional shares that he flips and Malhi is a top individual shareholder of millions of shares. The CEO believes it was ok to go to work for Malhi at First Responders Technologies under Kal Malhi's leadership. So who's the real boss at Algernon Pharmaceuticals? It ain't the CEO that's for sure! All these guys are in cahoots and they're doing it basically in the open daring us to do something about it. It's a TRUMP mentality. Do it in the open and people will think it’s legitimate. It's not legit. It's harmful to those not in the loop getting pep talks. It’s insane. 


P E R I O D


BH

 
[/quote]

<< Previous
Bullboard Posts
Next >>